One of our readers emailed me about using ursolic acid; one of the best known ways to assist the myeloma drugs we take to work better. As Gail’s questions became more specific, I decided to ask our resident expert, Danny Parker, to help out, too. Here is what he had to say: Gail, I included
Ever take Revlimid? Wonder where the tens of thousands of dollars that Medicare or your private insurance company pays for it goes each month? To finance speculative acquisitions of small, start-up pharmaceutical companies, of course! A few short weeks after acquiring the rights to one of the hottest yet unproven anti-myeloma therapy agents, MorphoSys' MOR202,
Recently I ran a series of posts about baseball great Don Baylor. He is one of the most famous MLB multiple myeloma survivors I know; but certainly not the only one. Former New York Yankee player, Mel Stottlemyre, is also a survivor. Here's a link to a New York Daily News human interest story about
Yesterday's post generated quite a bit of interest. Here's what I know about CD38 and MOR202 In January 2012, a 19 year old company that specializes in human antibody research, MorphoSys, received a U.S. patent for MOR202, a fully human HuCAL antibody. This new antibody was designed to use CD38 as a therapeutic target for
Hello from cold (for Florida) sunny Orlando! ASH starts later today, but I'm getting an early start. Still plenty to learn and share. For those of you who just can't get enough multiple myeloma related technical information, here is a link to a power point presentation about an experimental anti-myeloma anti-body, MOR202.Lots of photos, charts and graphs.